Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Obama to nominate Dr Robert Califf as FDA commissioner

Thecardiologist is the frontrunner to replace Margaret Hamburg

- PMLiVE

J&J’s Invokana receives new FDA safety warning

Additional trial data highlights bone problems

- PMLiVE

Lilly’s Cyramza not backed in draft NICE guidance

Institute says drug is not a cost-effective use of NHS resources

PureTech appoints new chief financial officer

Former Biogen VP Michael Maclean joins company

Patient-Centricity: Improving the model with patient journeys

Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

Blue Latitude Health

- PMLiVE

Janssen launches Stelara in the UK for adolescents

Psoriasis drug now available for younger patients

Daiichi Sankyo logo

Daiichi Sankyo licenses clot-busting antibody

New drug TS23 could be more much effective for ischemic stroke

- PMLiVE

Imbruvica filed as first-line leukaemia therapy

Study shows improved progression-free survival

- PMLiVE

Wave adds senior programme executive

Mehwish Abdeali joins the medical education agency from Circle Health

- PMLiVE

AbbVie’s Humira wins ninth US approval

FDA approves multi-blockbuster for inflammatory skin disease

- PMLiVE

Pricing of Novartis’ Entresto about right, concludes ICER

Supports potential for $5bn-a-year brand 

Sanofi reception

Sanofi plans LixiLan filings after positive phase III trial

Combination drug could cause dynamic shift in diabetes treament

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links